HOME › DRUGS › SPARSENTAN
ACTIVE SUBSTANCE / INN

SPARSENTAN

Brand name(s): Filspari, FILSPARI
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA216403
Glomerulonephritis, IGA
ACTIVE SUBSTANCE
Sparsentan
REGULATORS
FDA · EMA
SPONSORS / MAH
Vifor France, TRAVERE
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
FILSPARINDA216403TRAVEREPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FilspariVifor FranceAuthorised19/04/2024Glomerulonephritis, IGA

FULL INTELLIGENCE ON SPARSENTAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →